<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Blasczyk H</submitter><funding>NIAID NIH HHS</funding><funding>National Institutes of Health</funding><funding>Canadian Institutes of Health Research</funding><pagination>e178089</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12578392</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>135(21)</volume><pubmed_abstract>Sustained CD4+ T cell immunity is required for resolution of acute hepatitis C virus (HCV) infection, but the response remains poorly characterized. Here, circulating CD4+ T cells with high programmed cell death 1 (PD-1) and ICOS coexpression were temporally associated with onset of virus control, seroconversion, and hepatitis in HCV-infected chimpanzees. Coproduction of T follicular helper (Tfh) (IL-21 and CXCL13) and Th1 (IFN-γ and TNF) cytokines after stimulation with HCV nonstructural proteins demonstrated that the response was predominately Tfh1 like and virus specific. Transcriptional analysis verified a Tfh1 lineage assignment. Effector-related genes such as ADGRG1 (GPR56), ZNF683 (Hobit), and KLRB1 (CD161) were also expressed. HCV-specific PD-1hiICOShi CD4+ Tfh1-like cells were enr</pubmed_abstract><journal>The Journal of clinical investigation</journal><pubmed_title>A liver-infiltrating CD4+ Tfh1 cell response predicts HCV control, hepatitis, and seroconversion during acute infection.</pubmed_title><pmcid>PMC12578392</pmcid><funding_grant_id>U01AI131313</funding_grant_id><funding_grant_id>R01 AI126890</funding_grant_id><funding_grant_id>U19AI159819</funding_grant_id><funding_grant_id>R01AI136533</funding_grant_id><funding_grant_id>U19 AI159819</funding_grant_id><funding_grant_id>PJT-173467</funding_grant_id><funding_grant_id>U01 AI131313</funding_grant_id><funding_grant_id>R01 AI136533</funding_grant_id><funding_grant_id>R01AI190069</funding_grant_id><funding_grant_id>R01AI126890</funding_grant_id><funding_grant_id>R01 AI190069</funding_grant_id><pubmed_authors>Blasczyk H</pubmed_authors><pubmed_authors>Bremer W</pubmed_authors><pubmed_authors>Phelps CC</pubmed_authors><pubmed_authors>Skinner N</pubmed_authors><pubmed_authors>Bowen DG</pubmed_authors><pubmed_authors>Lanford R</pubmed_authors><pubmed_authors>Grakoui A</pubmed_authors><pubmed_authors>Walker CM</pubmed_authors><pubmed_authors>Zhou Y</pubmed_authors><pubmed_authors>Xu Z</pubmed_authors><pubmed_authors>Shoukry NH</pubmed_authors></additional><is_claimable>false</is_claimable><name>A liver-infiltrating CD4+ Tfh1 cell response predicts HCV control, hepatitis, and seroconversion during acute infection.</name><description>Sustained CD4+ T cell immunity is required for resolution of acute hepatitis C virus (HCV) infection, but the response remains poorly characterized. Here, circulating CD4+ T cells with high programmed cell death 1 (PD-1) and ICOS coexpression were temporally associated with onset of virus control, seroconversion, and hepatitis in HCV-infected chimpanzees. Coproduction of T follicular helper (Tfh) (IL-21 and CXCL13) and Th1 (IFN-γ and TNF) cytokines after stimulation with HCV nonstructural proteins demonstrated that the response was predominately Tfh1 like and virus specific. Transcriptional analysis verified a Tfh1 lineage assignment. Effector-related genes such as ADGRG1 (GPR56), ZNF683 (Hobit), and KLRB1 (CD161) were also expressed. HCV-specific PD-1hiICOShi CD4+ Tfh1-like cells were enr</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Nov</publication><modification>2026-06-05T07:18:38.855Z</modification><creation>2026-05-14T03:08:47.406Z</creation></dates><accession>S-EPMC12578392</accession><cross_references><pubmed>40956619</pubmed><doi>10.1172/JCI178089</doi></cross_references></HashMap>